Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
May 29, 2024 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond Vennare, Chief Executive...
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, May 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that positive results from a retrospective...
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
May 10, 2024 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, May 10, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine
April 30, 2024 16:05 ET
|
Predictive Oncology Inc.
PITTSBURGH, April 30, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announces a collaboration with FluGen to bring a...
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024 16:05 ET
|
Predictive Oncology Inc.
PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that an abstract has been accepted for...
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
March 28, 2024 17:28 ET
|
Predictive Oncology Inc.
PITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology to Participate in Upcoming Investor Conferences
February 21, 2024 16:05 ET
|
Predictive Oncology Inc.
PITTSBURGH, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...
Predictive Oncology to Participate in Upcoming San Francisco Conferences
January 02, 2024 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive...
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
November 14, 2023 07:00 ET
|
Predictive Oncology Inc.
PITTSBURGH, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...